4//SEC Filing
Serafini-Lamanna Tony 4
Accession 0001567619-23-001527
CIK 0000794172other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 2:09 PM ET
Size
17.0 KB
Accession
0001567619-23-001527
Insider Transaction Report
Form 4
Serafini-Lamanna Tony
Executive VP-Diagnostics
Transactions
- Disposition to Issuer
Common Stock
2023-01-31−43,338→ 0 total - Disposition to Issuer
Stock Option (Right to Buy)
2023-01-31$27.03/sh−4,000$108,120→ 0 totalExercise: $6.97Exp: 2030-03-26→ Common Stock (4,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-01-31$15.52/sh−12,107$187,901→ 0 totalExercise: $18.48Exp: 2030-11-05→ Common Stock (12,107 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-01-31$15.12/sh−11,669$176,435→ 0 totalExercise: $18.88Exp: 2031-11-04→ Common Stock (11,669 underlying) - Award
Common Stock
2023-01-31+7,945→ 43,338 total - Disposition to Issuer
Stock Option (Right to Buy)
2023-01-31$19.40/sh−10,000$194,000→ 0 totalExercise: $14.60Exp: 2028-04-30→ Common Stock (10,000 underlying)
Footnotes (6)
- [F1]Represents 7,945 shares of the Issuer's common stock awarded to the Reporting Person upon the vesting of a portion of an award of performance stock units ("PSUs") in connection with the closing of the transactions contemplated by the Merger Agreement (as defined below).
- [F2]The shares were disposed of pursuant to the Agreement and Plan of Merger dated as of July 7, 2022 (the "Merger Agreement") by and among the Issuer and SD Biosensor, Inc., a corporation with limited liability organized under the laws of the Republic of Korea whereby, immediately prior to the effective time of the merger contemplated therein (the "Effective Time"), all issued and outstanding shares of Issuer common stock were converted into the right to receive $34.00 per share in cash and, when so converted, automatically cancelled.
- [F3]The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment.
- [F4]The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment.
- [F5]The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment.
- [F6]The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment.
Documents
Issuer
MERIDIAN BIOSCIENCE INC
CIK 0000794172
Entity typeother
Related Parties
1- filerCIK 0001812602
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 2:09 PM ET
- Size
- 17.0 KB